Form D · Biotechnology
Biothera, Inc.
Eagan, MN · CIK 1303653
Offering snapshot reported Apr 12, 2010 · SEC filing
- Reported sold
- $3.5M Offering amount: $25M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2010 | Initial | $3,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-140375
Source: Form D, filed Apr 12, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Martha Jane Conners | Director |
| Daniel Kevin Conners | Director |
| William Leonard Gacki | Executive |
| Alexander Rocco Giaquinto, Ph D | Director |
| Robert Paul Hill | Director |
| Steven John Karel | Director, Executive |
| Steven Garth King | Director |
| Richard Gerald Mueller | Director, Executive |
| Dwight Alexander Porter, Md | Director |
| John Schlundt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3388 Mike Collins Drive
Eagan, MN, 55121
Eagan, MN, 55121